References
- Srouji LS, Moore-Clingenpeel M, Hensley J, et al. shock severity modifies associations between RBC transfusion in the first 48 hours of sepsis onset and the duration of organ dysfunction in critically ill septic children. Pediatr Crit Care Med. 2020;21(8):e475–e484. doi:10.1097/PCC.0000000000002338
- Zhang Q, Shan F. The role of p38 mitogen-activated protein kinase signaling pathway in the sepsis with multiple organ dysfunction syndrome. Chin J Cell Biol. 2018. Available from: https://d.wanfangdata.com.cn/periodical/xbswxzz201802018. Accessed October 19, 2021.
- Bojana M, Roy H, Frédéric M, et al. Conservative management of pelvic sepsis with severe shock and multiple organ dysfunction syndrome after rubber-band ligation of internal haemorrhoids: surgery is not the only option. J Surg Case Rep. 2018;2018(8):8.
- Ziesmann MT, Marshall JC. Multiple organ dysfunction: the defining syndrome of sepsis. Surg Infect (Larchmt). 2018;19(2):184–190. doi:10.1089/sur.2017.298
- Drobatz KJ, Hopper K, Rozanski E, et al. Textbook of Small Animal Emergency Medicine || Systemic Inflammatory Response Syndrome, Sepsis, and Multiple Organ Dysfunction Syndrome. John Wiley & Sons; 2018.
- Zhang L, Zhang T, Bian K, Wu D. Clinical effect of CHVHF on severe sepsis complicated with multiple organ dysfunction syndrome and its effect on hemodynamics. Clin Res Pract. 2018. Available from: https://wenku.baidu.com/view/bce38cc2e3bd960590c69ec3d5bbfd0a7956d5ae?fr=xueshu. Accessed October 19, 2021.
- Troia R, Giunti M, Goggs R. Plasma procalcitonin concentrations predict organ dysfunction and outcome in dogs with sepsis. BMC Vet Res. 2018;14(1):111. doi:10.1186/s12917-018-1427-y
- Ramirez JA. A continuum of disease from community-acquired pneumonia to multiple organ dysfunction syndrome. Univ Louisville J Respir Infect. 2018;2:4–6. doi:10.18297/jri/vol2/iss2/1/
- Alcamo A, Pang D, Bashir D, et al. Role of damage-associated molecular patterns and uncontrolled inflammation in pediatric sepsis-induced multiple organ dysfunction syndrome. J Pediatr Intensive Care. 2019;08(01):025–031. doi:10.1055/s-0038-1675639
- Gatica S, Eltit F, Santibanez J, et al. Expression suppression and activity inhibition of TRPM7 regulate cytokine production and multiple organ dysfunction syndrome during endotoxemia: a new target for sepsis. Curr Mol Med. 2019;19(8):547–559. doi:10.2174/1566524019666190709181726
- Kell DB, Pretorius E. To what extent are the terminal stages of sepsis, septic shock, systemic inflammatory response syndrome, and multiple organ dysfunction syndrome actually driven by a prion/amyloid form of fibrin? Semin Thromb Hemost. 2018;44(03):224–238. doi:10.1055/s-0037-1604108
- Cheng Z, Abrams ST, Alhamdi Y, et al. Circulating histones are major mediators of multiple organ dysfunction syndrome in acute critical illnesses. Crit Care Med. 2019;47(8):e677–e684. doi:10.1097/CCM.0000000000003839
- Zhang YJ, Zhuo XA, Zhou XM, Dai WJ. Prognostic value of lactate/albumin ratio in the elderly sepsis patients complicated with multiple organ dysfunction syndrome. Chin J Multiple Organ Dis Elder. 2018. Available from: https://d.wanfangdata.com.cn/periodical/zhlndqgjbzz201804003. Accessed October 19, 2021.
- Man-Xue M, Zhi-Guang WU, Jin-Li F, et al. Overview of Chinese medicine for treatment of sepsis with multiple organ dysfunction. J Guangzhou Univ Trad Chin Med. 2019.
- Vallejos A, Olivares P, Gatica S, et al. Endotoxemia-induced endothelial fibrosis inhibition improves hypotension, tachycardia, multiple organ dysfunction syndrome, cytokine response, oxidative stress, and survival. Lab Investig. 2019;99(8):1173–1192.
- Huang W, Qin S, Sun Y, et al. [Establishment of multiple organ dysfunction syndrome early warning score in patients with severe trauma and its clinical significance: a multicenter study]. Zhonghua W Zhong Bing Ji Jiu Yi Xue. 2018;30(1):41–46. Chinese.
- Xie J, Yang F, Chen J, Wang W, Yi C, Bai X. Application of vacuum sealing drainage in treatment of open fractures and multiple organ dysfunction syndrome. J Trauma Surg. 2018. Available from: http://qikan.cqvip.com/Qikan/Article/Detail?id=675978887&from=Qikan_Search_Index. Accessed October 19, 2021.
- Uchida M, Abe T, Ono K, et al. Ulinastatin did not reduce mortality in elderly multiple organ failure patients: a retrospective observational study in a single center ICU. Acute Med Surg. 2018;5(1):90–97. doi:10.1002/ams2.304
- Wu D, Shi S, Zhang R, et al. Expression and clinical significance of the novel inhibitory cytokine IL-3S in patients with sepsis and multiple organ dysfunction syndrome. Chin J Emerg Med. 2019;28(2):175–180.
- Zhang WF, Chen DM, Wu LQ, et al. Clinical effect of continuous blood purification in treatment of multiple organ dysfunction syndrome in neonates. Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics. 2020;22(1):31–36.